InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M

9 February, 2021

NEWS

24 March, 2021

InteRNA Technologies Publishes Preclinical Data from Investigational microRNA INT-1B3 Program in Molecular Therapy – Nucleic Acids and Oncotarget

21 March, 2021

InteRNA and the renewed interest in RNA therapeutics in the March 2021 edition of MedNous

11 March, 2021

InteRNA Technologies Awarded € 2.7M Clinical Innovation Credit from Dutch Government

16 February, 2021

InteRNA Technologies Announces Dosing of First Patient in First-in-Human Trial of microRNA Drug Candidate INT-1B3 in Patients with Advanced Solid Tumors

9 February, 2021

InteRNA Technologies Extends Series B Financing Round Totaling EUR 18.5M

1-5 6-10 11-15 16-20 21-25 26-30 31-35 36-40 41-41